Nicholas Fields

Nicholas Fields, Ph.D, has extensive work experience in the pharmaceutical and medical field. Nicholas is currently working as a Principal Medical Writer at ICON plc since 2022. Prior to that, they worked as an owner, drug development consultant, and medical/regulatory writer at Sagecon Inc. from 2003 to 2023, where they provided guidance for drug discovery/development processes and conducted due diligence assessments.

Before joining Sagecon Inc., Nicholas served as an Executive Director Clinical at Hemosol from 2001 to 2003. In this role, they developed FDA-approved protocols, resolved FDA issues, and expanded clinical trial programs for the company's lead product.

Earlier in their career, Nicholas held the position of Associate Director Clinical Research at SmithKline Beecham from 1993 to 2001. During this tenure, they managed clinical trials across various therapeutic areas, implemented electronic data capture for studies, and successfully led a group involved in numerous studies with high enrollment numbers.

Overall, Nicholas Fields, Ph.D, brings a wealth of experience in clinical research, drug development, medical writing, and regulatory affairs to their current role at ICON plc.

Dr. Nicholas Fields earned their Doctor of Philosophy (Ph.D.) in Pharmacology from Western University between 1976 and 1986.